Rosetta Genomics Ltd. of Princeton, New Jersey, a developer and provider of microRNA-based and other molecular diagnostics, recently received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. 14/446,505, titled “Compositions and Methods for the Prognosis and Treatment of Prostate Cancer,” a patent that is designed to provide an effective prostate cancer treatment. 

Boehringer Ingelheim and BioMed X have teamed up to develop a crowdsourcing approach to put together a research team; the team, made up of scientists from around the globe, will work toward finding new ways to treat patients suffering from chronic obstructive pulmonary disease (COPD), which is a chronic, progressive and treatable -- but incurable -- lung disease, which currently affects nearly 210 million people around the world.

True Human therapeutic antibody therapy being developed to treat all forms of staph infections.

Lonsurf is an oral medication used to treat advanced colorectal cancer.

A recent study conducted by the Government Accountability Office (GAO) found that the federal government's program mandating that doctors and hospitals maintain electronic health records for patients actually might be impeding the exchange of data between electronic health records systems.

The U.S. Food and Drug Administration (FDA) granted approval for Aristada (aripiprazole lauroxil), an extended-release injection, for the treatment of adults with schizophrenia on Monday. Aristada, a product of Dublin, Ireland-based biopharmaceutical company Alkermes, is administered by a health care professional every four to six weeks by injection in the arm or buttocks.

Bayer HealthCare said it has received approval from the U.S. Food and Drug Administration for Betaconnect, the first-of-its-kind electronic autoinjector indicated for the treatment of relapsing-remitting multiple sclerosis. The product is expected to be available in early 2016 to patients who take Betaseron (interferon beta-1b). Betaseron is used to decrease the number of relapses in MS patients.

The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Global pharmaceutical company AbbVie's Viekirax, a treatment for adult patients living with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection. Japan has one of the highest rates of hepatitis C infection in the industrialized world, with an estimated 1.5 to 2 million people living with the disease.

Government agencies and private payers are being lobbied by the AAFP, who wants to make sure that patients with diabetes have access to the medical supplies they need.

A recent health proposal by Democratic presidential candidate Hillary Clinton is facing by the Biotechnology Industry Organization, which said it would do more harm than good to Americans.

Limits on patient eligibility are making it difficult for some primary care physicians to switch over from private insurance to direct primary care (DPC) practice models.

Biogen and Swedish Orphan Biovitrum AB (Sobi) have received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to market Elocta.

K2M Group Holdings Inc. has commercially launched its spinal technology.

AstraZeneca representatives gave presentations on oncology research at the 2015 European Cancer Congress (ECC) in Vienna.

After President Obama signed into law the Protecting Affordable Care for Employees Act, U.S. Sen. Tim Scott (R-SC) issued a statement supporting the measure on Thursday. "With the PACE Act quickly signed into law, we have taken a great step forward in protecting small and mid-size businesses from the harmful effects of Obamacare," Scott said.

New legislation was introduced recently by U.S. Sens. Bill Cassidy (R-LA) and Sheldon Whitehouse (D-RI) that they said would strengthen accountability and improve transparency in health information technology systems.

Researchers at the Technical University of Denmark's Systems Biology department have developed groundbreaking diagnostic technology that, based on a biopsy from a metastasis, can with 85 percent accuracy identify a cancer source. The new method relies on an analysis of DNA mutations in cancer tissue samples from patients with metastasized cancers.

U.S. Sen. Susan Collins (R-ME) took to the Senate floor on Thursday to show her support for the Mental Health Reform Act of 2015. Collins is the co-sponsor of the bipartisan measure, which would address the lack of resources for those struggling with mental illness, as well as improve coordination to help develop solutions that would lead to better outcomes for families dealing with mental illness.

Induced hypothermia therapy may even harm one's recovery.

These virtual reality models have been under development at the University of Montreal Hospital Research Center's radiology, radiation oncology and nuclear medicine departments.